| Quote | Spy MYL NEW ![]() |
Message Board | |||||
|
Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders. |
|
Earnings highlights: Aetna, Allergan, E*Trade, Goodyear, RadioShack, SAP, Visa ...
XOM GT MYL RSH SNE AGN COG MFE ITG SAP EL ETFC NVTL TROW AET SXL AMTD BARE V Linked by BloggingStocks - October 31, 04:43PM from (www.bloggingstocks.com) Here are some highlights from last week's earnings coverage from BloggingStocks: Aetna Inc. (NYSE: AET) more ...
Pharma earnings recap: Mylan, Allergan, Novo-Nordisk
MYL AGN Linked by BloggingStocks - October 30, 02:44PM from (www.bloggingstocks.com) One would expect generic U.S. drugmaker Mylan (NYSE: MYL) to benefit from all this talk about increased generic competitions, more ...
Mylan Labs Tops Q3 EPS by 5c, Guides Higher
MYL Linked by StreetInsider - October 29, 06:43AM from (www.streetinsider.com) more ...
Mylan Reports Third Quarter Adjusted Diluted EPS of $0.32
MYL Posted by PR Newswire - October 29, 06:30AM PITTSBURGH, Oct. 29 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced its financial results for the three and nine months ended September 30, 2009. more ...
Mylan Declares Quarterly Preferred Stock Dividend
MYL Posted by PR Newswire - October 20, 07:00AM PITTSBURGH, Oct. 20 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that in accordance with its 2.139 more ...
Are CBS And Sprint At Risk For Bankruptcy?
AMD AMR GT IPG MYL S TXT CAL OSK CBS SIRI AIV RWT AMKR LVS LCAPA HTZ FDML Linked by 24/7 Wall St. - September 18, 02:34PM from (feedproxy.google.com) Audit Integrity, a research firm, has come out with a list of the large American companies which are most likely to go bankrupt more ...
Mylan Laboratories "average," target price raised
MYL Linked by newratings - September 10, 01:13PM from (www.newratings.com) NEW YORK, September 10 (newratings.com) - Analysts at Caris & Company reiterate their "average" rating on Mylan more ...
Mylan’s Deeply Flawed Legal And PR Move
MYL Linked by 24/7 Wall St. - August 19, 11:40AM from (feedproxy.google.com) Robert Coury, the CEO of Mylan (MYL), his general counsel, and public affairs staff don't know how to quit when they are ahead. more ...
Mylan Tops Q2 Views; Guides Above the Street
MYL Linked by StreetInsider - July 30, 07:55AM from (www.streetinsider.com) more ...
Teva Gains on Earnings, Denies Michael Jackson Connection
MYL TEVA PRGO HITK NVS RDY Linked by tickerspy blog - July 28, 12:43PM from (www.tickerspy.com) Teva Pharmaceuticals (TEVA) profits beat expectations in the second quarter, despite slipping year-over-year. more ...
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Home | About | Register | My tickerspy | Logout | Web site design by LightMix |
| © 2009 Indie Research, LLC. All rights reserved. | |
---
Institutional Holdings Disclaimer Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter. Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time. tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors. THE INFORMATION PROVIDED TO YOU HEREUNDER IS PROVIDED "AS IS" AND TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, INDIE RESEARCH, LLC AND IT LICENSORS, BUSINESS ASSOCIATES AND SUPPLIERS DISCLAIM ALL WARRANTIES WITH RESPECT TO THE SAME, EXPRESS, IMPLIED AND STATUTORY, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY, COMPLETENESS AND NON-INFRINGEMENT. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, NEITHER INDIE RESEARCH, LLC NOR ITS OFFICERS, MEMBERS, DIRECTORS, PARTNERS, AFFILIATES, BUSINESS ASSOCIATES, LICNESORS OR SUPPLIERS WILL BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR PUNITIVE DAMAGES, INCLUDING WITHOUT LIMITATION DAMAGAES FOR LOST PROFITS OR REVENUES, GOODWILL, WORK STOPPAGE, SECURITY BREACHES, VIRUSES, COMPUTER FAILURE OR MALFUNCTION, USE, DATA OR OTHER INTANGIBLE LOSSES OR COMMERCIAL DAMAGES, EVEN IF ANY OF SUCH PARTIES ADVISED OF THE POSSIBILITY OF SUCH LOSSES, ARISING UNDER OR IN CONNECTION WITH THE INFORMATION PROVIDED HEREIN OR ANY OTHER SUBJECT MATTER HEREOF. |
|